Cargando…
Deprescribing psychotropic medicines for behaviours that challenge in people with intellectual disabilities: a systematic review
BACKGROUND: Clear evidence of overprescribing of psychotropic medicines to manage behaviours that challenges in people with intellectual disabilities has led to national programmes within the U.K. such as NHS England’s STOMP to address this. The focus of the intervention in our review was deprescrib...
Autores principales: | Adams, Danielle, Hastings, Richard P., Maidment, Ian, Shah, Chetan, Langdon, Peter E. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10044393/ https://www.ncbi.nlm.nih.gov/pubmed/36978032 http://dx.doi.org/10.1186/s12888-022-04479-w |
Ejemplares similares
-
Mental illness, challenging behaviour, and psychotropic drug prescribing in people with intellectual disability: UK population based cohort study
por: Sheehan, Rory, et al.
Publicado: (2015) -
Aligning quality of life and guidelines for off-label psychotropic drugs in adults with intellectual disabilities and challenging behaviour
por: Laermans, P., et al.
Publicado: (2023) -
Improving knowledge of psychotropic prescribing in people with Intellectual Disability in primary care
por: Shankar, Rohit, et al.
Publicado: (2018) -
Psychotropic drugs intake in people aging with intellectual disability: Prevalence and predictors
por: García‐Domínguez, Laura, et al.
Publicado: (2022) -
Challenging behaviours: Views and preferences of people with intellectual disabilities
por: Wolkorte, Ria, et al.
Publicado: (2019)